Ceeto Capital Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $783K | Hold |
6,200
| – | – | 0.21% | 99 |
|
|
2026
Q1 | $864K | Hold |
6,200
| – | – | 0.27% | 83 |
|
|
2025
Q4 | $761K | Hold |
6,200
| – | – | 0.22% | 94 |
|
|
2025
Q3 | $688K | Hold |
6,200
| – | – | 0.2% | 101 |
|
|
2025
Q2 | $687K | Hold |
6,200
| – | – | 0.24% | 100 |
|
|
2025
Q1 | $695K | Hold |
6,200
| – | – | 0.26% | 91 |
|
|
2024
Q4 | $573K | Hold |
6,200
| – | – | 0.21% | 98 |
|
|
2024
Q3 | $520K | Sell |
6,200
-10,000
| -62% | -$763K | 0.19% | 104 |
|
|
2024
Q2 | $1.11M | Hold |
16,200
| – | – | 0.43% | 54 |
|
|
2024
Q1 | $1.19M | Buy |
16,200
+500
| +3% | +$38.4K | 0.49% | 47 |
|
|
2023
Q4 | $1.27M | Hold |
15,700
| – | – | 0.55% | 44 |
|
|
2023
Q3 | $1.18M | Hold |
15,700
| – | – | 0.57% | 44 |
|
|
2023
Q2 | $1.21M | Hold |
15,700
| – | – | 0.55% | 47 |
|
|
2023
Q1 | $1.3M | Hold |
15,700
| – | – | 0.65% | 41 |
|
|
2022
Q4 | $1.35M | Hold |
15,700
| – | – | 0.74% | 38 |
|
|
2022
Q3 | $969K | Hold |
15,700
| – | – | 0.56% | 47 |
|
|
2022
Q2 | $970K | Sell |
15,700
-2,000
| -11% | -$124K | 0.53% | 50 |
|
|
2022
Q1 | $1.05M | Hold |
17,700
| – | – | 0.48% | 53 |
|
|
2021
Q4 | $1.28M | Hold |
17,700
| – | – | 0.54% | 51 |
|
|
2021
Q3 | $1.24M | Hold |
17,700
| – | – | 0.58% | 48 |
|
|
2021
Q2 | $1.22M | Buy |
17,700
+1,000
| +6% | +$66.8K | 0.55% | 51 |
|
|
2021
Q1 | $1.08M | Hold |
16,700
| – | – | 0.53% | 55 |
|
|
2020
Q4 | $973K | Buy |
16,700
+1,200
| +8% | +$72.4K | 0.49% | 56 |
|
|
2020
Q3 | $979K | Hold |
15,500
| – | – | 0.55% | 50 |
|
|
2020
Q2 | $1.19M | Hold |
15,500
| – | – | 0.77% | 40 |
|
|
2020
Q1 | $1.16M | Hold |
15,500
| – | – | 0.93% | 30 |
|
|
2019
Q4 | $1.01M | Sell |
15,500
-400
| -3% | -$26K | 0.66% | 47 |
|
|
2019
Q3 | $1.01M | Hold |
15,900
| – | – | 0.73% | 40 |
|
|
2019
Q2 | $1.07M | Buy |
15,900
+100
| +0.6% | +$6.58K | 0.79% | 40 |
|
|
2019
Q1 | $1.03M | Hold |
15,800
| – | – | 0.75% | 45 |
|
|
2018
Q4 | $988K | Hold |
15,800
| – | – | 0.82% | 43 |
|
|
2018
Q3 | $1.22M | Buy |
15,800
+400
| +3% | +$30.2K | 0.84% | 37 |
|
|
2018
Q2 | $1.09M | Buy |
15,400
+400
| +3% | +$28.2K | 0.82% | 40 |
|
|
2018
Q1 | $1.13M | Hold |
15,000
| – | – | 0.86% | 38 |
|
|
2017
Q4 | $1.07M | Hold |
15,000
| – | – | 0.77% | 42 |
|
|
2017
Q3 | $1.22M | Buy |
+15,000
| New | +$1.15M | 0.91% | 37 |
|
Other funds holding GILD
Ceeto Capital Group's GILD Position: Q2 2026 in Review
Ceeto Capital Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 6,200 shares worth $783K. The position accounts for 0.21% of the portfolio, ranked #99.
Ceeto Capital Group first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.35M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ceeto Capital Group held 6,200 shares of Gilead Sciences worth $783K as of Q2 2026.
- Ceeto Capital Group left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.21% of Ceeto Capital Group's portfolio in Q2 2026, its #99 holding.
- Ceeto Capital Group first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- Ceeto Capital Group's Gilead Sciences position peaked at $1.35M in Q4 2022.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ceeto Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.